Document is current
Any future updates will be listed below
-
Authors
Polzin, Amin
Helten, Carolin https://orcid.org/0000-0001-8066-2239
Metzen, Daniel
Zako, Saif
Veulemans, Verena
Kelm, Malte
Zeus, Tobias
-
Funding
Funding for this research was provided by:
Forschungskommission of the Medical Faculty of the Heinrich Heine University Duesseldorf (18-2019, 51-2020)
German Research Foundation (PO 2247/2-1, SFB1116)
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
- License Information
-
More Information
Article History
Accepted: 13 October 2022
First Online: 1 November 2022
Declarations
:
: Amin Polzin declares consulting and paid speaking fees for Bayer, Bristol-Myers Squibb/Pfizer and Daiichi Sankyo. Tobias Zeus declares consulting and paid speaking fees for Bayer and Daiichi Sankyo. Carolin Helten, Daniel Metzen, Saif Zako, Verena Veulemans and Malte Kelm have nothing to declare.
: The study conformed to the Declaration of Helsinki and was accepted by the Ethics Committee of the Heinrich-Heine University of Düsseldorf, Germany.
: Informed written consent was obtained from all study patients.
